CeplignanCAS# 185244-78-4 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 185244-78-4 | SDF | Download SDF |
PubChem ID | 102004693 | Appearance | Powder |
Formula | C18H18O7 | M.Wt | 346.3 |
Type of Compound | Lignans | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2S,3R)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-carboxylic acid | ||
SMILES | COC1=CC(=CC2=C1OC(C2CO)C3=CC(=C(C=C3)O)OC)C(=O)O | ||
Standard InChIKey | MRHRLMTUTXWEQP-BLLLJJGKSA-N | ||
Standard InChI | InChI=1S/C18H18O7/c1-23-14-6-9(3-4-13(14)20)16-12(8-19)11-5-10(18(21)22)7-15(24-2)17(11)25-16/h3-7,12,16,19-20H,8H2,1-2H3,(H,21,22)/t12-,16+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. (2S,3R)-Ceplignan and (2R,3S)-Ceplignan significantly enhances SERT activity, can used in treatments of neuropsychiatric and digestive disorders. |
Targets | 5-HT Receptor |
Ceplignan Dilution Calculator
Ceplignan Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.8877 mL | 14.4383 mL | 28.8767 mL | 57.7534 mL | 72.1917 mL |
5 mM | 0.5775 mL | 2.8877 mL | 5.7753 mL | 11.5507 mL | 14.4383 mL |
10 mM | 0.2888 mL | 1.4438 mL | 2.8877 mL | 5.7753 mL | 7.2192 mL |
50 mM | 0.0578 mL | 0.2888 mL | 0.5775 mL | 1.1551 mL | 1.4438 mL |
100 mM | 0.0289 mL | 0.1444 mL | 0.2888 mL | 0.5775 mL | 0.7219 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Loganin
Catalog No.:BCN1153
CAS No.:18524-94-2
- Scabertopin
Catalog No.:BCN4685
CAS No.:185213-52-9
- Butabindide oxalate
Catalog No.:BCC7020
CAS No.:185213-03-0
- Chrysin 6-C-glucoside 8-C-arabinoside
Catalog No.:BCN1516
CAS No.:185145-34-0
- Chrysin 6-C-arabinoside 8-C-glucoside
Catalog No.:BCN1517
CAS No.:185145-33-9
- Ethyl 1,2,5,6-tetrahydropyridine-3-carboxylate
Catalog No.:BCC8299
CAS No.:18513-76-3
- Decoquinate
Catalog No.:BCC4654
CAS No.:18507-89-6
- R 715
Catalog No.:BCC6014
CAS No.:185052-09-9
- Liquidambaric lactone
Catalog No.:BCN2301
CAS No.:185051-75-6
- Brevifolincarboxylic acid
Catalog No.:BCN3884
CAS No.:18490-95-4
- 5-Benzyl-1H-tetrazole
Catalog No.:BCC8741
CAS No.:18489-25-3
- NNC 05-2090 hydrochloride
Catalog No.:BCC7472
CAS No.:184845-18-9
- Rp-8-Br-PET-cGMPS
Catalog No.:BCC7538
CAS No.:185246-32-6
- GR 46611
Catalog No.:BCC5679
CAS No.:185259-85-2
- (R)-(+)-1,1'-Bi-2-naphthol
Catalog No.:BCC8393
CAS No.:18531-94-7
- Fmoc-3-(2-Pyridyl)-D-Alanine
Catalog No.:BCC2569
CAS No.:185379-39-9
- Fmoc-3-(2-Pyridyl)-Alanine
Catalog No.:BCC2568
CAS No.:185379-40-2
- TCS 1105
Catalog No.:BCC6087
CAS No.:185391-33-7
- O-Acetylethanolamine
Catalog No.:BCN1757
CAS No.:1854-30-4
- AF 12198
Catalog No.:BCC5812
CAS No.:185413-30-3
- Corchoionoside C
Catalog No.:BCN1154
CAS No.:185414-25-9
- Timorsaponin C
Catalog No.:BCN2899
CAS No.:185432-00-2
- ONO 2506
Catalog No.:BCC7943
CAS No.:185517-21-9
- BMS 961
Catalog No.:BCC7680
CAS No.:185629-22-5
A novel sesquiterpene and three new phenolic compounds from the rhizomes of Acorus tatarinowii Schott.[Pubmed:26296476]
Bioorg Med Chem Lett. 2015 Oct 1;25(19):4214-8.
A novel sesquiterpene with an unprecedented epoxy lactone skeleton, named tatarinolactone, together with two new amides, a new biphenylpropanoid and two known lignans were isolated from the rhizomes of Acorus tatarinowii Schott. Their structures were identified as 6,7,8-trihydroxy-4alpha-isobutyl-4,7-dimethylhexahydro-6,8alpha-epoxychromen-2(3H )-one (1), (E)-methyl 4-[3-(4-hydroxy-3-methoxyphenyl)acrylamido]butanoate (2), (Z)-methyl 4-[3-(4-hydroxy-3-methoxyphenyl)acrylamido]butanoate enol isomer (3), (R)-4-hydroxy-3-[1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)propan-2-yl]-5-methoxyben zoic acid (4), (2S,3R)-Ceplignan (5), and (2R,3S)-Ceplignan (6), respectively, based on extensive spectroscopic analysis and by comparison to the known compounds. To test their effects on serotonin transporters, a high content assay using hSERT-HEK293 cell line was adopted. Results indicated that compounds 1 and 4 significantly inhibited SERT activity, while compounds 2, 3, 5, and 6 significantly enhanced SERT activity, which partly explain the traditional uses of the rhizomes of Acorus tatarinowii Schott in treatments of neuropsychiatric and digestive disorders.